Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 2768  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded166    
    Comments [Add]    

Recommend this journal


Year : 2017  |  Volume : 65  |  Issue : 7  |  Page : 60--70

Management of brain tumor-related epilepsy

1 Department of Neurosurgery, Wayne State University School of Medicine, Detroit, Michigan, USA
2 Department of Neurology, Wayne State University School of Medicine; Comprehensive Epilepsy Center, Detroit Medical Center and Wayne State University, Detroit, Michigan, USA
3 Department of Neurosurgery; Oncology, Wayne State University School of Medicine; Comprehensive Epilepsy Center, Detroit Medical Center and Wayne State University; Multidisciplinary Neuro-Oncology Program, Karmanos Cancer Institute, Detroit, Michigan, USA

Correspondence Address:
Sandeep Mittal
Department of Neurosurgery, Wayne State University, 4160 John R Street, Suite 930, Detroit, Michigan - 48201
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/neuroindia.NI_1076_16

Rights and Permissions

Seizures are common in both primary and metastatic brain tumors, although the rate of seizures differ significantly between the different types of neoplasms. Patients with brain tumor-associated seizures need treatment with antiepileptic drugs (AEDs) to prevent recurrence, whereas strong clinical data exists to discourage routine prophylaxis in patients who have not had seizures. The newer AEDs, such as levetiracetam, lamotrigine, lacosamide, topiramate, or pregabalin, are preferable for various reasons, primarily related to the side-effect profile and limited interactions with other drugs. If seizures persist despite initiation of an appropriate monotherapy (in up to 30–40% of cases), additional anticonvulsants may be necessary. Early surgical intervention improves seizure outcomes in individuals with medically refractory epilepsy, especially in patients with a single lesion that is epileptogenic. Data for this review article were compiled by searching for scholarly articles using the following keywords: brain tumor, epilepsy, seizure, tumor-related epilepsy, central nervous system, epidemiology, review, clinical trial, and surgery. Articles were screened for relevance by title and abstract, and selected for review and inclusion based on significant contribution to the topics discussed.


Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow